cyclobenzaprine hydrochloride Overview Categories 20 Muscle relaxants and cholinesterase inhibitors Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Griseofulvin Manufacturers of Griseofulvin Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Griseofulvin's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 5 to 10 mg7.5 (7.5)8 hourlyPOUse of Cyclobenzaprine Hydrochloride for periods longer than two or three weeks is not recommended. Less frequent dosing should be considered for hepatically impaired or elderly patients Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Griseofulvin is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Griseofulvin is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Griseofulvin Back to top Manufacturers of cyclobenzaprine hydrochloride in Pakistan Atco CCL Dyson R L Getz MAQ Novamed Opal Pharmevo Back to top Previous Drug Generic - Next Drug Generic
cyclobenzaprine hydrochloride Overview Categories 20 Muscle relaxants and cholinesterase inhibitors Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Griseofulvin Manufacturers of Griseofulvin Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Griseofulvin's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 5 to 10 mg7.5 (7.5)8 hourlyPOUse of Cyclobenzaprine Hydrochloride for periods longer than two or three weeks is not recommended. Less frequent dosing should be considered for hepatically impaired or elderly patients Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Griseofulvin is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Griseofulvin is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Griseofulvin Back to top Manufacturers of cyclobenzaprine hydrochloride in Pakistan Atco CCL Dyson R L Getz MAQ Novamed Opal Pharmevo Back to top Previous Drug Generic - Next Drug Generic